Navigation Links
SpineSmith to Present at the 5th Annual Stem Cell Summit
Date:2/15/2010

AUSTIN, Texas, Feb. 15 /PRNewswire/ -- Dr. Robert Johnson, MD, of Neurosurgical Associates of San Antonio, is presenting at the 5th Annual Stem Cell Summit in New York on February 16, 2010. Dr. Johnson will be presenting his most recent data proving the efficacy of point of care adult stem cell therapies in spine surgery.  Point of care technology utilizes the patient's own cells derived from bone marrow to inhibit bone growth in spinal fusion procedures.  Dr. Johnson believes promoting cell therapy utilizing the patient's own cells will change the future landscape of medicine.  

"The use of autologous stem cells is revolutionizing medical care in both the prevention and treatment of spinal disorders," said Johnson.

The annual Stem Cell Summit brings together the leading medical, financial and scientific innovators within the rapidly expanding field of regenerative medicine. SpineSmith has been an avid attendee and sponsor of the Stem Cell Summit for numerous years and built a business around the future of regenerative medicine.  SpineSmith launched Celling Technologies to research and develop cell therapies through the collaboration of scientists, engineers and medical providers in a wide spectrum of applications including spine, orthopedics, trauma, plastics, cardiovascular and disease.

Dr. James Poser, Vice President of Regenerative Medicine for Celling Technologies, believes the future of regenerative medicine is upon us and the science has quickly pushed technology to deliver results-based medicine.  Dr. Poser believes point of care technologies are quickly becoming a source for consistent, reliable and predictable results for cell therapies.

"It is through collaborative efforts like those with Dr. Johnson that Celling Technologies intends to rigorously investigate and expand the opportunities for the effective use of a patient's own cells in regenerative medicine.  The Stem Cell Summit has become a preeminent forum for sharing and discussing these developments, and we look forward to participating in this and future Summit meetings," said Poser.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine.

About Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine.  Celling's product offering focuses on autologous adult stem cell therapies and the devices and services that complement these procedures.  

About Neurosurgical Associates of San Antonio

Neurosurgical Associates of San Antonio provides comprehensive spine care across a full spectrum of neurologic and spinal surgery.   Neurosurgical Associates of San Antonio is committed to providing state-of-the-art neurosurgical and spine care as well as the highest quality of care, compassion and excellence to patients.

www.spinesmithusa.com

www.cellingtechnologies.com

SOURCE SpineSmith Partners, LP

RELATED LINKS
http://www.spinesmithusa.com
http://www.cellingtechnologies.com

'/>"/>

SOURCE SpineSmith Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement
2. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
3. SIU To Present System Technology & Innovation Expo March 30
4. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
5. European research initiative EUREKA presented at Research & Technology for the first time
6. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
7. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
8. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
9. Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
10. The Advisory Board Company to Present at Upcoming Conferences
11. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or ... pleased to announce that Biohaven has issued today the ... Connecticut (PRWEB) Dec 9, 2016 - Biohaven ... today that the U.S. Food and Drug Administration ("FDA") ... its drug candidate BHV-0223, an orally dissolving tablet being ...
(Date:12/8/2016)... PITTSBURGH , Dec. 8, 2016  The Board ... (PLSG), Western Pennsylvania,s only ... in leadership. In accordance with the succession plan developed ... several years, effective today, James (Jim) F. Jordan ... Executive Officer, succeeding John W. Manzetti , who ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... Lajollacooks4u, San ... a banner year for team building events, new program offerings and company expansion. ... expanded earlier this year to include groups of over 30 people. Ever since, Lajollacooks4u ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... platforms, the business of innovation is taking over sports. On Thursday, December 15th ... explore how technology is disrupting the playing field at a Smart Talk session. ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):